首頁 > 市場調查報告書 > 製藥

眼科藥物

北美乾眼產品市場預測至 2031 年 - 區域分析 - 按產品、劑型、類型和配銷通路

市場調查報告書

商品編碼

1666250

北美乾眼產品市場預測至 2031 年 - 區域分析 - 按產品、劑型、類型和配銷通路

North America Dry Eye Products Market Forecast to 2031 - Regional Analysis - by Product, Dosage Form, Type, and Distribution Channel

出版日期: 2025年01月13日 | 出版商:

The Insight Partners | 英文 104 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2023年北美乾眼症產品市值為38.2536億美元，預計2031年將達到55.8777億美元；預計 2023 年至 2031 年的複合年成長率為 4.9%。

乾眼症盛行率上升推動北美乾眼症產品市場

乾眼症（DED）是繼屈光不正和白內障之後第三常見的眼科就診原因。乾眼症的盛行率在已開發國家尤其上升。乾眼症是由多種因素引起的，會導致不適、刺激和視覺障礙。根據美國眼科學會發表的一篇文章，全球每11人就有1人患有DED，不同年齡層的盛行率為5%至50%。根據愛爾康 2022 年發布的新聞稿，該疾病影響全球約 7.19 億人，其中美國約 3,800 萬人。

糖尿病視網膜病變對視網膜造成的逐漸損害進一步導致了乾眼症。根據美國眼科學會發表的一篇文章，預計到 2030 年，全球將有約 1.91 億人患有糖尿病視網膜病變。

北美乾眼產品市場概覽

北美乾眼產品市場分為美國、加拿大和墨西哥。該地區市場的成長歸因於人們對乾眼症 (DED) 認知的不斷提高、老齡化人口的成長、技術進步以及眼部疾病病例的增加。此外，由於新藥頻繁推出，各種藥物易於取得，是推動該地區乾眼症產品市場成長的關鍵因素之一。

DED 是美國常見但未被充分診斷的疾病，人口年齡的成長可能與疾病的盛行率激增有關。根據美國疾病管制與預防中心 (CDC) 的數據，白內障、黃斑部病變、糖尿病視網膜病變和青光眼等與年齡相關的眼部疾病是美國失明和視力受損的主要原因。其他常見的眼部疾病包括弱視和斜視。預計到2030年，美國將有多達279萬名男性患有乾眼症。 2021年1月，Kala Pharmaceuticals Inc.推出EYSUVIS 0.25%（氯替潑諾依碳酸酯眼用混懸液），用於短期（最長兩週）治療乾眼症症狀。 EYSUVIS 目前已在美國各地的國家和地區藥品配送中心推出。

北美乾眼產品市場收入及預測（2031 年）（百萬美元）

北美乾眼產品市場細分

北美乾眼產品市場分為產品、劑型、類型、配銷通路和國家。

根據產品，北美乾眼產品市場分為人工淚液、抗發炎藥、淚點塞、促泌劑、口服歐米茄補充劑等。 2023 年，人工淚液佔據了北美乾眼產品市場的最大佔有率。此外，淚點塞部分又細分為可溶解和可拆卸。

就劑型而言，北美乾眼產品市場分為眼藥水、凝膠、膠囊及錠劑等。 2023 年，眼藥水佔據了北美乾眼產品市場最大的佔有率。

根據類型，北美乾眼產品市場分為非處方藥和處方藥。 2023 年，OTC 部門佔據了北美乾眼產品市場的較大佔有率。

根據配銷通路，北美乾眼產品市場分為零售藥局、醫院藥局和網路藥局。 2023 年，零售藥局部門佔據了北美乾眼產品市場最大的佔有率。

依國家分類，北美乾眼產品市場分為美國、加拿大和墨西哥。 2023 年，美國佔據北美乾眼症產品市場的主導佔有率。

參天製藥株式會社、強生公司、OASIS Medical、URSAPHARM Arzneimittel GmbH、樂敦製藥有限公司、OCuSOFT Inc、博士倫醫療公司、艾伯維公司、Prestige Consumer Healthcare Inc、Farmigea SpA 和愛爾康公司。是北美乾眼產品市場的一些領先公司。

Dry eye disease (DED) ranks third among the most common reasons for visits to an ophthalmology clinic after refractive errors and cataracts, respectively. The prevalence of dry eye is particularly rising in developed nations. Dry eye is caused by multiple factors that result in discomfort, irritation, and visual disturbance. According to an article published by the American Academy of Ophthalmology, DED affects approximately 1 in 11 people worldwide, with prevalence ranging from 5% to 50% at various ages. According to a press release by Alcon in 2022, the disease affects ~719 million people globally and ~38 million people in the US.

Progressive damage caused to the retina due to diabetic retinopathy further results in DED. According to an article published by the American Academy of Ophthalmology, ~191.0 million people globally are estimated to suffer from diabetic retinopathy by 2030. As per the Centers for Disease Control and Prevention (CDC), approximately 9.6 million people (across all ages) in the US were living with diabetic retinopathy in 2021. Thus, the increasing incidence of diabetic retinopathy is driving the growth of the dry eye products market.

North America Dry Eye Products Market Overview

The North America dry eye products market is segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the increasing awareness of dry eyes disease (DED), growing aging population, technological advancements, and rising eye disease cases. Moreover, an easy availability of various drugs due to frequent launches of new drugs is one of the key factors propelling the dry eye products market growth in the region.

DED is a common but underdiagnosed condition in the US, and an increase in the population age can be associated with the surging prevalence of this disease. According to the Centers for Disease Control and Prevention (CDC), age-related eye diseases such as cataract, macular degeneration, diabetic retinopathy, and glaucoma are the primary causes of blindness and impaired vision in the US. Other common eye disorders include amblyopia and strabismus. Dry eye disease is expected to affect as many as 2.79 million US men by 2030. Thus, with the rising incidence of dry eye disease, the demand for therapeutic products is on the rise in the country. In January 2021, Kala Pharmaceuticals Inc. launched EYSUVIS 0.25% (loteprednol etabonate ophthalmic suspension) for the short-term (up to two weeks) treatment of dry eye disease symptoms. EYSUVIS is now available in national and regional pharmaceutical distribution centers across the US.

North America Dry Eye Products Market Revenue and Forecast to 2031 (US$ Million)

North America Dry Eye Products Market Segmentation

The North America dry eye products market is categorized into product, dosage form, type, distribution channel, and country.

Based on product, the North America dry eye products market is segmented into artificial tears, anti-inflammatory drugs, punctal plugs, secretagogues, oral omega supplements, and others. The artificial tears segment held the largest North America dry eye products market share in 2023. Furthermore, the anti-inflammatory drugs segment is subcategorized into cyclosporine, corticosteroid, and others. Additionally, the punctal plugs segment is subsegmented into dissolvable and removable.

In terms of dosage form, the North America dry eye products market is segmented into eye drops, gel, capsules and tablets, and others. The eye drops segment held the largest North America dry eye products market share in 2023.

By type, the North America dry eye products market is bifurcated into OTC and prescription. The OTC segment held a larger North America dry eye products market share in 2023.

Based on distribution channel, the North America dry eye products market is categorized into retail pharmacy, hospital pharmacy, and online pharmacy. The retail pharmacy segment held the largest North America dry eye products market share in 2023.

By country, the North America dry eye products market is segmented into the US, Canada, and Mexico. The US dominated the North America dry eye products market share in 2023.

Santen Pharmaceutical Co Ltd, Johnson & Johnson, OASIS Medical, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co Ltd, OCuSOFT Inc, Bausch Health Companies Inc, AbbVie Inc, Prestige Consumer Healthcare Inc, Farmigea SpA, and Alcon AG. are some of the leading companies operating in the North America dry eye products market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Dry Eye Products Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rising Prevalence of Dry Eye
- 4.1.2 Upsurge in Geriatric Population
4.2 Market Restraints
- 4.2.1 Side Effects of Eye Drops and Product Recalls
4.3 Market Opportunities
- 4.3.1 Increasing Initiatives for Eye Care Awareness
4.4 Future Trends
- 4.4.1 Ongoing Research and Growing Pipeline for Dry Eye Products
4.5 Impact of Drivers and Restraints:

5. Dry Eye Products Market - North America Analysis

5.1 North America Dry Eye Products Market Revenue (US$ Million), 2021-2031

6. North America Dry Eye Products Market Analysis - by Product

6.1 Overview
6.2 Artificial Tears
- 6.2.1 Overview
- 6.2.2 Artificial Tears: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Anti-Inflammatory Drugs
- 6.3.1 Overview
- 6.3.2 Anti-Inflammatory Drugs: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  - 6.3.2.1 North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
6.4 Punctal Plugs
- 6.4.1 Overview
- 6.4.2 Punctal Plugs: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  - 6.4.2.1 North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
6.5 Secretagogues
- 6.5.1 Overview
- 6.5.2 Secretagogues: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
6.6 Oral Omega Supplements
- 6.6.1 Overview
- 6.6.2 Oral Omega Supplements: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
6.7 Others
- 6.7.1 Overview
- 6.7.2 Others: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

7. North America Dry Eye Products Market Analysis - by Dosage Form

7.1 Overview
7.2 Eye Drops
- 7.2.1 Overview
- 7.2.2 Eye Drops: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Gels
- 7.3.1 Overview
- 7.3.2 Gels: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Capsules and Tablets
- 7.4.1 Overview
- 7.4.2 Capsules and Tablets: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Dry Eye Products Market Analysis - by Type

8.1 Overview
8.2 OTC
- 8.2.1 Overview
- 8.2.2 OTC: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Prescription
- 8.3.1 Overview
- 8.3.2 Prescription: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Dry Eye Products Market Analysis - by Distribution Channel

9.1 Overview
9.2 Retail Pharmacies
- 9.2.1 Overview
- 9.2.2 Retail Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Hospital Pharmacies
- 9.3.1 Overview
- 9.3.2 Hospital Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Online Pharmacies
- 9.4.1 Overview
- 9.4.2 Online Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Dry Eye Products Market - Country Analysis

10.1 North America: Dry Eye Products Market
- 10.1.1 North America: Dry Eye Products Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.1.1 United States: Dry Eye Products Market Breakdown, by Product
    - 10.1.1.1.1.1 United States: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
    - 10.1.1.1.1.2 United States: Dry Eye Products Market Breakdown, by Punctal Plugs
    - 10.1.1.1.2 United States: Dry Eye Products Market Breakdown, by Dosage Form
    - 10.1.1.1.3 United States: Dry Eye Products Market Breakdown, by Type
    - 10.1.1.1.4 United States: Dry Eye Products Market Breakdown, by Distribution Channel
  - 10.1.1.2 Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.2.3 Canada: Dry Eye Products Market Breakdown, by Product
    - 10.1.1.2.3.1 Canada: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
    - 10.1.1.2.3.2 Canada: Dry Eye Products Market Breakdown, by Punctal Plugs
    - 10.1.1.2.4 Canada: Dry Eye Products Market Breakdown, by Dosage Form
    - 10.1.1.2.5 Canada: Dry Eye Products Market Breakdown, by Type
    - 10.1.1.2.6 Canada: Dry Eye Products Market Breakdown, by Distribution Channel
  - 10.1.1.3 Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.3.3 Mexico: Dry Eye Products Market Breakdown, by Product
    - 10.1.1.3.3.1 Mexico: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
    - 10.1.1.3.3.2 Mexico: Dry Eye Products Market Breakdown, by Punctal Plugs
    - 10.1.1.3.4 Mexico: Dry Eye Products Market Breakdown, by Dosage Form
    - 10.1.1.3.5 Mexico: Dry Eye Products Market Breakdown, by Type
    - 10.1.1.3.6 Mexico: Dry Eye Products Market Breakdown, by Distribution Channel

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Dry Eye Products Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Santen Pharmaceutical Co Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Johnson & Johnson
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 OASIS Medical
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 URSAPHARM Arzneimittel GmbH
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Rohto Pharmaceutical Co Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 OCuSOFT Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Bausch Health Companies Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 AbbVie Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Prestige Consumer Healthcare Inc.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Farmigea SpA
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Alcon AG
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. North America Dry Eye Products Market Segmentation
Table 2. North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
Table 3. North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
Table 4. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 5. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
Table 6. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
Table 7. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
Table 8. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 9. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
Table 10. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 11. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
Table 12. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
Table 13. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
Table 14. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 15. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
Table 16. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 17. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
Table 18. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
Table 19. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
Table 20. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 21. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
Table 22. Recent Organic Growth Strategies in the Dry Eye Products Market
Table 23. Recent Inorganic Growth Strategies in the Dry Eye Products Market
Table 24. Glossary of Terms

List Of Figures

Figure 1. North America Dry Eye Products Market Segmentation, by Country
Figure 2. North America Dry Eye Products Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Dry Eye Products Market Revenue (US$ Million), 2021-2031
Figure 5. Dry Eye Products Market Share (%) - by Product (2023 and 2031)
Figure 6. Artificial Tears: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Anti-Inflammatory Drugs: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Punctal Plugs: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Secretagogues: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Oral Omega Supplements: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Others: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. North America Dry Eye Products Market Share (%) - by Dosage Form (2023 and 2031)
Figure 13. Eye Drops: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Gels: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Capsules and Tablets: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Others: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. North America Dry Eye Products Market Share (%) - by Type (2023 and 2031)
Figure 18. OTC: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Prescription: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Dry Eye Products Market Share (%) - by Distribution Channel (2023 and 2031)
Figure 21. Retail Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Hospital Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Online Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. North America: Dry Eye Products Market, by Key Country - Revenue (2023) (US$ Million)
Figure 25. North America: Dry Eye Products Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. Growth Strategies in the Dry Eye Products Market